Cullinan Oncology(CGEM) - 2023 Q2 - Quarterly Report

26 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. Cullinan Oncology, Inc. Date: August 10, 2023 By : /s/ Nadim Ahmed Name: Nadim Ahmed Title: President and Chief Executive Officer (Principal Executive Officer) Date: August 10, 2023 By : /s/ Jeffrey Trigilio Name: Jeffrey Trigilio Title: Chief Financial Officer (Principal Financial and Accounting Of ...